Genomic Tumor Board Archives - American Cancer Society ECHO

Genomic Tumor Board

Beth Dickson-Gavney | November 3, 2023

A Genomic tumor board (GTB) consists of a team of multidisciplinary healthcare professionals who collaborate to review genomic tumor tests (GTT). These boards function to analyze results of GTTs to help guide potential treatment decisions using the latest research. The goal of these sessions is to work together to provide interpretation support for clinicians and engage community oncologists in a robust discussion of treatment options for the patient and evaluate actionable results.

Protected: Genomic Tumor Board ECHO

Beth Dickson-Gavney | November 3, 2023

There is no excerpt because this is a protected post.

Protected: Genomic Tumor Board ECHO – 1-31-24 Recording

Allison Rosen | February 5, 2024

There is no excerpt because this is a protected post.

Protected: Genomic Tumor Board ECHO – 2-21-24 Recording

Allison Rosen | February 22, 2024

There is no excerpt because this is a protected post.

Protected: Genomic Tumor Board ECHO – 3-20-24 Recording

Allison Rosen | March 20, 2024

There is no excerpt because this is a protected post.

Protected: Genomic Tumor Board ECHO – 4-17-24 Recording

Allison Rosen | April 17, 2024

There is no excerpt because this is a protected post.

Protected: Genomic Tumor Board ECHO -12-12-23- Recording

Allison Rosen | December 13, 2023

There is no excerpt because this is a protected post.

Protected: Genomic Tumor Board ECHO -12-12-23- Slides

Allison Rosen | December 13, 2023

There is no excerpt because this is a protected post.

This Website is administered by the American Cancer Society, Inc. on behalf of the Office of Cancer Research & Implementation. Copyright © 2024 American Cancer Society ECHO American Cancer Society, Inc.

Privacy Policy